Townsend Richard Nolan

SEC source: 0001995218-26-000017 · form4-09282026_050901.xml · derivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,500

Underlying: Common Stock · 145,500 shares

Expires 2036-09-23

F3 · derivative.exercise_date: 25% of the shares underlying the option vest and become exercisable on September 24, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001995218-26-000017 · form4-09282026_050901.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,778

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).

F2 · balance_after: Includes 242,911 Restricted Stock Units.

SEC source: 0001995218-26-000015 · form4-08192026_050805.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 374,472

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $4.83 to $5.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 242,911 Restricted Stock Units.

SEC source: 0001995218-26-000013 · form4-07012026_100715.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,817

F1 · kind: Represents a sale to cover tax obligations on the release of performance Restricted Stock Units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $4.3402 to $4.7507. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 252,130 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

SEC source: 0001995218-26-000013 · form4-07012026_100715.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,764

SEC source: 0001995218-26-000011 · form4-05202026_040505.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 336,764

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $5.03 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 252,130 Restricted Stock Units.

SEC source: 0001995218-26-000009 · form4-04072026_040401.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 340,106

F1 · kind: The sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $5.56 to $5.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 261,349 Restricted Stock Units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001995218-26-000006 · form4-03182026_010332.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,106

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).

F2 · balance_after: Includes 261,349 Restricted Stock Units.

SEC source: 0001995218-26-000004 · form4-02202026_050203.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,483

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $6.22 to $6.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 261,349 Restricted Stock Units.

SEC source: 0001995218-26-000002 · form4-02062026_050205.xml · derivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 646,665

Underlying: Common Stock · 260,000 shares

Expires 2036-02-03

F3 · derivative.exercise_date: 25% of the shares underlying the option vest and become exercisable on February 4, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001995218-26-000002 · form4-02062026_050205.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,656

F1 · shares: The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.

F2 · balance_after: Includes 290,022 RSUs.

SEC source: 0001995218-25-000007 · form4-11202025_101125.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,991

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 128,357 Restricted Stock Units.

SEC source: 0001995218-25-000005 · form4-10172025_111000.xml · nonDerivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,118

F1 · kind: Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs").

F3 · price: This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4 · balance_after: Includes 131,092 RSUs. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.

SEC source: 0001995218-25-000005 · form4-10172025_111000.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,266

F1 · kind: Represents a sale to cover tax obligations on the release of Restricted Stock Units ("RSUs").

F2 · price: This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001995218-25-000005 · form4-10172025_111000.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,251

SEC source: 0001995218-25-000003 · form4-09162025_050903.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,251

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).

F2 · balance_after: Includes 131,092 Restricted Stock Units.

SEC source: 0001415889-25-022473 · form4-08202025_090813.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,058

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · balance_after: Includes 131,092 RSUs.

SEC source: 0001415889-25-024104 · form4a-09102025_080929.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,058

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · shares: On August 20, 2025, the reporting person filed a Form 4 which inadvertently reported the disposition of 2,735 securities. In fact, as reported in this amendment, the reporting person disposed of 1,115 shares of Common Stock on August 18, 2025.

F3 · balance_after: Includes 131,092 Restricted Stock Units.

SEC source: 0001415889-25-013819 · form4-05202025_050509.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,173

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · balance_after: Includes 133,827 RSUs.

SEC source: 0001415889-25-009450 · form4-04012025_110414.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 222,247

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d).

SEC source: 0001415889-25-005113 · form4-02212025_100221.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,119

F1 · kind: Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").

F2 · balance_after: Includes 136,562 RSUs.

SEC source: 0001415889-25-001287 · form4-01102025_040110.xml · derivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,500

Underlying: Common Stock · 207,500 shares

Expires 2035-01-06

F3 · derivative.exercise_date: 25% of the shares underlying the option vest and become exercisable on January 7, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-25-001287 · form4-01102025_040110.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,445

F1 · shares: The reported securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date.

F2 · balance_after: Includes 147,500 RSUs.

SEC source: 0001415889-24-029143 · form4-12122024_051206.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,655

Underlying: Common Stock · 2,500 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-029143 · form4-12122024_051206.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $7.98 to $8.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-029143 · form4-12122024_051206.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-026737 · form4-11132024_101126.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,155

Underlying: Common Stock · 2,500 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-026737 · form4-11132024_101126.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $7.49 to $8.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-026737 · form4-11132024_101126.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-025110 · form4-10152024_011001.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-025110 · form4-10152024_011001.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $7.99 to $8.3591. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-025110 · form4-10152024_011001.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-023233 · form4-09112024_090900.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-023233 · form4-09112024_090900.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $10.37 to $10.925. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-023233 · form4-09112024_090900.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-021245 · form4-08132024_100801.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 133,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-021245 · form4-08132024_100801.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $11.05 to $11.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-021245 · form4-08132024_100801.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · nonDerivative · entry 5

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F5 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · nonDerivative · entry 4

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,795

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $16.7476 to $17.4703. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · derivative · entry 6

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 138,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F6 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · nonDerivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,726

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.83 to $16.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 152,073

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.83 to $16.825. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001415889-24-019526 · form4-07122024_040703.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0001415889-24-016518 · form4-06122024_050602.xml · derivative · entry 4

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 143,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F5 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001415889-24-016518 · form4-06122024_050602.xml · nonDerivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $17.78 to $18.67. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

SEC source: 0001415889-24-016518 · form4-06122024_050602.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 172,733

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $16.80 to $17.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

SEC source: 0001415889-24-016518 · form4-06122024_050602.xml · nonDerivative · entry 1

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

SEC source: 0000950170-24-059506 · ownership.xml · derivative · entry 3

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 148,655

Underlying: Common Stock · 5,000 shares

Expires 2031-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 25% of the shares underlying the option vested on November 21, 2021, and 1/48th of the shares underlying the option vested or shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0000950170-24-059506 · ownership.xml · nonDerivative · entry 2

Townsend Richard Nolan · CIK 0001995218 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 170,695

F1 · kind: The exercises and sales in this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $12.98 to $13.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3 · balance_after: Includes 43,750 restricted stock units (RSU's). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.